Stockscreener 앱 받기
3.28
2.38%
-0.08
시간 외 거래:
3.31
0.03
+0.91%
전일 마감가:
$3.36
열려 있는:
$3.34
하루 거래량:
5.51M
Relative Volume:
0.88
시가총액:
$1.01B
수익:
$348.97M
순이익/손실:
$5.86M
주가수익비율:
195.24
EPS:
0.0168
순현금흐름:
$13.69M
1주 성능:
+14.69%
1개월 성능:
+27.63%
6개월 성능:
-37.52%
1년 성능:
-31.81%
1일 변동 폭
$3.245
$3.43
1주일 범위
$3.245
$4.29
52주 변동 폭
$2.23
$6.51
맨카인드 Stock (MNKD) Company Profile
명칭
Mannkind Corp
전화
818-661-5000
주소
1 CASPER STREET, DANBURY, CA
Compare MNKD vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
3.28 | 1.04B | 348.97M | 5.86M | 13.69M | 0.0168 |
VRTX
Vertex Pharmaceuticals Inc
|
448.29 | 110.45B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
723.41 | 74.73B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
812.81 | 50.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
292.03 | 38.03B | 4.29B | 577.22M | 641.34M | 4.2086 |
ONC
Beone Medicines Ltd Adr
|
315.07 | 32.24B | 5.76B | 514.49M | 1.10B | 4.4813 |
맨카인드 Stock (MNKD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-27 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-11-13 | 개시 | Leerink Partners | Outperform |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-10-10 | 개시 | Leerink Partners | Outperform |
| 2025-07-16 | 재개 | H.C. Wainwright | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-10 | 개시 | Wedbush | Outperform |
| 2024-12-20 | 개시 | Wells Fargo | Overweight |
| 2024-12-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-10-10 | 개시 | Wedbush | Outperform |
| 2021-05-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | 개시 | Oppenheimer | Outperform |
| 2019-10-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-05-14 | 개시 | BTIG Research | Buy |
| 2019-03-04 | 개시 | SVB Leerink | Outperform |
| 2019-02-22 | 개시 | SVB Leerink | Outperform |
| 2018-02-28 | 다운그레이드 | Maxim Group | Hold → Sell |
| 2017-11-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2017-10-10 | 개시 | H.C. Wainwright | Buy |
| 2017-10-06 | 재확인 | Maxim Group | Buy |
| 2017-08-11 | 개시 | Maxim Group | Buy |
| 2016-05-10 | 재확인 | Piper Jaffray | Underweight |
| 2016-05-10 | 재확인 | RBC Capital Mkts | Underperform |
| 2016-01-06 | 재확인 | Piper Jaffray | Underweight |
| 2016-01-06 | 재확인 | RBC Capital Mkts | Underperform |
| 2015-11-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | 다운그레이드 | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-05-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2015-05-11 | 재확인 | MLV & Co | Hold |
| 2015-04-16 | 재확인 | RBC Capital Mkts | Outperform |
모두보기
맨카인드 주식(MNKD)의 최신 뉴스
MNKD stock records biggest single-day gains in over 5 years, breaches a key technical milestone – what’s driving this rally? - MSN
[144] MANNKIND CORP SEC Filing - Stock Titan
10 Best Penny Stocks to Buy Before They Explode - Insider Monkey
State Street (NASDAQ: MNKD) holds 18.68M shares, 6.1% stake - Stock Titan
MannKind Corp stock (US5638651064): Q1 2026 earnings miss on EPS, revenue up 15% - AD HOC NEWS
The $59B Quiet Shift Reshaping How Patients Access Care - Benzinga
H.C. Wainwright and Wells Fargo Lift MannKind (MNKD) Price Targets - Insider Monkey
TradingKey - TradingKey
5 Best US Stocks Under $5 to Buy - Insider Monkey
MNKD Technical Analysis & Stock Price Forecast - Intellectia AI
MNKD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Q1 2026 MannKind Corp Earnings Call Transcript - GuruFocus
Wall Street Zen Downgrades MannKind (NASDAQ:MNKD) to Sell - MarketBeat
MannKind (MNKD) CEO clarifies 100,000-share Form 4 error in amendment - Stock Titan
MannKind (MNKD) Is Up 25.4% After Mixed Q1 Results and Expanded United Therapeutics Partnership – What's Changed - Yahoo Finance
MNKD Maintained by RBC Capital -- Price Target Raised to $4.75 - GuruFocus
MNKD Maintains Overweight Rating -- Price Target Raised to $10.0 - GuruFocus
MannKind Corporation (NASDAQ:MNKD) Q1 2026 Earnings Call Transcript - Insider Monkey
MNKD Stock Price, Quote & Chart | MANNKIND CORP (NASDAQ:MNKD) - ChartMill
MannKind Q1 2026 slides: revenue up 15%, three catalysts ahead By Investing.com - Investing.com Canada
MannKind (NASDAQ:MNKD) Announces Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
MannKind Q1 Earnings Call Highlights - Yahoo Finance
MannKind Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
MannKind Q1 2026 slides: revenue up 15%, three catalysts ahead - Investing.com
Compared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Earnings call transcript: MannKind Q1 2026 sees revenue growth, stock surges - Investing.com
MannKind (MNKD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
MannKind Corp (NASDAQ:MNKD) Q1 2026 Revenue Miss and Wider EPS Loss Overshadow Strong Pipeline Progress - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
MannKind: Q1 Earnings Snapshot - Barchart.com
Revenue growth but net loss for MannKind (NASDAQ: MNKD) in Q1 2026 - Stock Titan
MannKind heads into two FDA decisions after posting $90.2M in Q1 - Stock Titan
MannKind (NASDAQ: MNKD) Q1 2026 revenue rises 15% as Furoscix ramps - Stock Titan
MNKD Stock Records Biggest Single-Day Gains In Over 5 Years, Breaches A Key Technical Milestone – What’s Driving This Rally? - Stocktwits
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Keep an eye on the top gainers and losers in Wednesday's session. - ChartMill
Why is MannKind stock surging today? By Investing.com - Investing.com Canada
Why is MannKind stock surging today? - Investing.com
MannKind stock surges on United Therapeutics partnership deal - Investing.com
Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday - Benzinga
Wednesday's session: gap up and gap down stocks - ChartMill
MannKind advances inhaled ralinepag program for lung diseases - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
MannKind develops inhaled ralinepag formulation for United Therapeutics By Investing.com - Investing.com South Africa
MannKind develops inhaled ralinepag formulation for United Therapeutics - Investing.com
At least five PDUFA dates on FDA’s May docket - BioCentury
MNKD Technical Analysis | Trend, Signals & Chart Patterns | MANNKIND CORP (NASDAQ:MNKD) - ChartMill
Is MannKind Corporation (MNKD) The Best Fundamentally Strong Penny Stock to Invest In Now? - Insider Monkey
5 Best Fundamentally Strong Penny Stocks to Invest In Now - Insider Monkey
MannKind settles $36.3M convertible notes with cash, shares - Investing.com
MannKind (MNKD) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
맨카인드 (MNKD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
자본화:
|
볼륨(24시간):